NCT07437391 Effect of L-Carnitine Supplementation in Preterm Neonates
| NCT ID | NCT07437391 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Muhammad Aamir Latif |
| Condition | Respiratory Distress Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2026-06-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.
Eligibility Criteria
Inclusion Criteria: * Preterm neonates * Either gender * With RDS * Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth . Exclusion Criteria: * Neonates with gastrointestinal tract (GIT) anomalies * With confirmed or suspected sepsis at the time of enrollment * Neonates whose clinical condition contraindicates study participation (e.g., expected survival \<48 hours, as judged by the neonatologist).